Search & Analyze
Popular Searches
Mono Pharmacare Ltd.
Trading₹10.50
CMP₹10.50
Mkt Cap₹19 Cr
P/E52.56
P/B0.59
ROE10.47%
52W High₹0.00
52W Low₹0.00
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
52.56
P/B Ratio
0.59
EV/EBITDA
17.81
Price/Sales
0.11
Dividend Yield (%)
0.00
EPS (TTM ₹)
0.20
Book Value (₹)
17.66
ROE (%)
10.47
ROCE (%)
11.00
ROA (%)
3.25
EBITDA Margin (%)
4.54
Net Profit Margin (%)
1.84
Debt/Equity
1.72
Current Ratio
2.07
Interest Coverage
2.11
Asset Turnover
1.76
Working Capital/Sales
2.99
Core EBITDA Growth (%)
34.14
P&L
| Particulars | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|
| Gross Sales | 2699.05 | 12234.02 | 16834.49 |
| Net Sales | 2699.05 | 12234.02 | 16834.49 |
| Total Income | 2722.31 | 12243.56 | 16932.37 |
| Total Expenditure | 2547.51 | 11601.15 | 16070.66 |
| Operating Profit | 174.8 | 642.41 | 861.71 |
| Depreciation | 4.74 | 11.52 | 12.87 |
| Exceptional Items | — | — | — |
| Profit Before Tax | 92.96 | 322.6 | 446.29 |
| Tax | 22.81 | 76.72 | 135.7 |
| Profit After Tax (PAT) | 70.15 | 245.88 | 310.59 |
| EPS (₹) | 0.71 | 1.5899999999999999 | 1.75 |
| Dividend Payout % | — | — | — |
Balance Sheet
| Particulars | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|
| Share Capital | 1236.86 | 1766.86 | 1766.86 |
| Reserves | 101.47 | 1044.04 | 1353.06 |
| Shareholders Funds | 1338.33 | 2810.9 | 3119.92 |
| Total Debt | 4049.78 | 4144.03 | 5356.03 |
| Total Liabilities | 6254.76 | 8110.1 | 11001.03 |
| Total Assets | 6254.76 | 8110.1 | 11001.03 |
| Book Value / Share | 10.8204 | 15.909 | 17.658 |
| Assets | 6254.76 | 8110.1 | 11001.03 |
Cash Flows
| Particulars | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|
| Operating Activities | -2775.39 | -877.18 | -430.28 |
| Investing Activities | -143.64 | 39.84 | -22.63 |
| Financing Activities | 2960.8 | 831.84 | 486.4 |
| Net Cash Flow | 41.77 | -5.5 | 33.49 |
MONOPHARMA
₹10.50
+0%